Kenneth Gordon, MD - Potential Clinical Implications of the Latest Data on Approved and Emerging Therapies for Psoriasis: A Recap From Washington, DC

Go online to PeerView.com/YDK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses select abstracts focused on psoriasis that were presented at the 2019 American Academy of Dermatology (AAD) Annual Meeting, held from March 1-5, in Washington, DC. An overview and practical insights are offered on new data that speak to a rapidly evolving treatment landscape in psoriasis. Upon completion of this activity, participants should be better able to: Apply new data on the efficacy, safety, and optimal clinical use of approved therapies when managing patients with psoriasis, Assess the potential clinical utility of late-breaking data on the efficacy, safety, and tolerability of emerging therapeutic options for the treatment of psoriasis, Identify the potential impact of emerging therapies on the future management of psoriasis, particularly in patients with difficult-to-treat disease.